Company Information & Drug Savings for Elan Pharma Medications
Elan Pharmaceuticals, acquired by Perrigo, was a specialty pharmaceutical company focused on central nervous system and autoimmune disease treatments. Known for developing Tysabri (natalizumab) for multiple sclerosis and Crohn’s disease in partnership with Biogen. Elan’s drug delivery technologies and neurology expertise contributed to important advances in treating chronic neurological conditions.
How to Contact Elan Pharma
Phone
1-800-859-8586Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
